What Influences Physicians' Decisions - Statistics or Stories?

• ClinicalTrials.gov Identifier: NCT02048982
• Recruitment Status: Withdrawn
• First Posted: January 29, 2014
• Last Update Posted: September 12, 2018
• Sponsor: Weill Medical College of Cornell University
• Collaborator: Duke University
• Information provided by (Responsible Party): Weill Medical College of Cornell University

Study Description

Brief Summary:

The purpose of this study is to test whether physicians change their use of non-recommended tests, procedures, or medications more in response to evidence based-guidelines, price information, or an individual patient's story.

Condition or disease	Intervention/treatment	Phase
Prescribing Tendencies	Behavioral: Guideline; Behavioral: Cost; Behavioral: Victim	Not Applicable

Detailed Description:

We will perform a randomized controlled trial (RCT) of information presented to physicians to test the hypothesis that an identifiable victim affects physician practice behavior more than a statistical victim.

Specifically, we will answer the following research questions: 1) do physicians order fewer non-recommended tests, procedures, or medications if they are told about a patient or a physician who had a bad outcome from that test, procedure, or medication than if they are simply told the guideline or the cost of the test, procedure or medication, 2) does the effect of learning about the identifiable victim last longer than the effect of learning about the guideline or the cost of a test, procedure, or medication, and 3) does the identifiable victim effect differ if the victim is a patient or a physician? We hypothesize that because of the propensity to respond more to the identifiable victim rather than the statistical victim that physicians will order fewer unnecessary tests when they are told about an individual patient case than if they are simply told about the guideline, that the effect of the identifiable victim will last longer than the effect of the statistical victim, and that a patient as the identifiable victim will have more effect than a physician as the identifiable victim.

The identifiable victim effect refers to the tendency to offer more aid to a specific, identifiable victim rather than a vaguely defined group of people with the same need. In the this study, the identifiable victim is a fictional patient who experience a negative consequence as a result of an unnecessary test. The identifiable victim effect is described and studied in the following articles:

Small D. Sympathy and callousness: The impact of deliberative thought on donations to identifiable and statistical victims. Organizational Behavior and Human Decision Processes 2007;102:143-53.

George Loewenstein, Deborah A. Small, and Jeff Strand. "Statistical, identifiable, and iconic victims" in Edward J. McCaffery, Joel Slemrod (2006). Behavioral public finance. Russell Sage Foundation; pp. 32-35.

Study Design

• Study Type: Interventional (Clinical Trial)
• Actual Enrollment: 0 participants
• Allocation: Randomized
• Intervention Model: Parallel Assignment
• Masking: Double (Participant, Investigator)
• Primary Purpose: Health Services Research
• Official Title: What Influences Physicians' Decisions - Statistics or Stories?
• Study Start Date: February 2014
• Actual Primary Completion Date: September 2015
• Actual Study Completion Date: December 2015

Arms and Interventions

Arm	Intervention/treatment
Experimental: Guideline and Cost; The Choosing Wisely guideline and the cost of the test at our institution: $60.35 for a basic metabolic panel.	Behavioral: Guideline; Physicians will receive information on the Choosing Wisely Guideline; Behavioral: Cost; Physicians will receive cost information.
Placebo Comparator: Guideline; The Choosing Wisely guideline: "Don't perform blood chemistry panels in asymptomatic, healthy adults."	Behavioral: Guideline; Physicians will receive information on the Choosing Wisely Guideline
Active Comparator: Guideline and Victim; The Choosing Wisely Guideline and a clinical scenario with a patient as an identifiable victim who suffered harm from having an unnecessary test done	Behavioral: Guideline; Physicians will receive information on the Choosing Wisely Guideline; Behavioral: Victim; Physicians will receive information on an identifiable victim.
Experimental: Guideline, Cost, and Victim; The Choosing Wisely guideline and a clinical scenario with a physician as an identifiable victim who suffered harm when he ordered an unnecessary test.	Behavioral: Guideline; Physicians will receive information on the Choosing Wisely Guideline; Behavioral: Cost; Physicians will receive cost information.; Behavioral: Victim; Physicians will receive information on an identifiable victim.

Outcome Measures

Primary Outcome Measures :

1. Percentage of blood chemistry tests among visits by adult patients under 65 [ Time Frame: Within 1 week of receiving the intervention ]
2. Percentage of blood chemistry tests among visits by adult patients under 65 [ Time Frame: Within 1 month of receiving the scenario ]

Secondary Outcome Measures :

1. Physicians' attitudes and perceived practice immediately after reading the scenario [ Time Frame: Immediate (up to 5 min) ]

Eligibility Criteria

• Ages Eligible for Study: Child, Adult, Older Adult
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Criteria

Inclusion Criteria:

• Primary care physicians in the Weill Cornell Physicians Organization

Exclusion Criteria:

• None

Contacts and Locations

Locations

United States, New York

Weill Cornell Medical College

New York, New York, United States, 10065

Sponsors and Collaborators

Weill Medical College of Cornell University

Duke University

More Information

• Responsible Party: Weill Medical College of Cornell University
• ClinicalTrials.gov Identifier: NCT02048982
• Other Study ID Numbers: Bishop_stats_stories
• First Posted: January 29, 2014
• Last Update Posted: September 12, 2018
• Last Verified: September 2018

Keywords provided by Weill Medical College of Cornell University:

physician prescribing; behavioral economics; primary care practice